We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing Point of Care Clotting Tests in the OR Versus Standard Laboratory Clotting Tests

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00892905
First Posted: May 5, 2009
Last Update Posted: March 2, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
McMaster University
May 4, 2009
May 5, 2009
March 2, 2011
January 2008
January 2011   (Final data collection date for primary outcome measure)
Correlation between pre cardiopulmonary bypass (CPB) and post CPB POC INR and PTT with standard laboratory INR and PTT [ Time Frame: 2 months ]
Same as current
Complete list of historical versions of study NCT00892905 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparing Point of Care Clotting Tests in the OR Versus Standard Laboratory Clotting Tests
Comparison Between Point of Care INR and aPTT Hemochron Jr Whole Blood Measurement With Standard Laboratory in Patients Having Elective First Time on Pump Coronary Artery Bypass Grafting (CABG)
The purpose of this study is determine the agreement of point of care (POC) clotting tests (INR and aPTT) by the POC device by Hemochron Jr versus standard laboratory clotting tests (INR and aPTT) in patients undergoing elective cardiac surgery.
The study is a correlation between POC Hemochron Jr INR and aPTT with the standard.
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Adult patient undergoing elective on pump CABG
Coronary Artery Bypass Grafting
Not Provided
POC INR and APTT Hemochron
Adult patients undergoing elective on pump coronary artery bypass grafting surgery who have not received anticoagulants or clopidogrel within 5 days preoperatively.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
January 2011
January 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • did not receive anticoagulants or clopidogrel within 5 days preoperatively

Exclusion Criteria:

  • history of coagulopathy
  • heparin resistance
  • receiving heparin or warfarin
  • hepatic or renal dysfunction
  • pregnancy
  • urgent or emergency cases
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00892905
07-467
No
Not Provided
Not Provided
Dr. Summer Syed, MD, Hamilton Health Sciences
Hamilton Health Sciences Corporation
Not Provided
Principal Investigator: Summer Syed, MD Hamilton Health Sciences Corporation
McMaster University
January 2011